Working… Menu

A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Subcutaneous Histamine Dihydrochloride for Migraine Prophylaxis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02021474
Recruitment Status : Unknown
Verified January 2015 by AgoneX Biopharmaceuticals, Inc..
Recruitment status was:  Not yet recruiting
First Posted : December 27, 2013
Last Update Posted : January 27, 2015
Information provided by (Responsible Party):
AgoneX Biopharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : September 2016
Study Completion Date : No date given